Avaliação clínica de bochechos com extratos de Aroeira (Schinus terebinthifolius) e Camomila (Matricaria recutita L. ) sobre a placa bacteriana e a gengivite / Clinical evaluation of mouthwash with extracts from aroeira (Schinus terebinthifolius) and chamomile (Matricaria recutita L. ) on plaque and gingivitis

A presente pesquisa objetivou avaliar clinicamente o efeito de bochechos à base de extratos das plantas medicinais, aroeira (Schinus terebinthifolius) e camomila (Matricaria recutita L.), sobre o controle da placa bacteriana e o tratamento da gengivite. Para tanto, foi realizado um ensaio clínico randomizado, duplo cego, intervencionista, envolvendo 59 indivíduos adultos atendidos na Clínica do Curso de Odontologia da Universidade Estadual da Paraíba (UEPB). A amostra foi constituída por pacientes portadores de gengivite crônica. A referida amostra foi selecionada aleatoriamente e dividida em três grupos: bochecho com Clorexidina (grupo controle positivo); bochecho com Camomila (grupo teste 1); bochecho com Aroeira (grupo teste 2). Durante a primeira visita do paciente, e, previamente à realização dos bochechos, todos foram orientados quanto à higiene bucal e submetidos ao procedimento de raspagem e alisamento radicular (RAR) da boca toda em uma única sessão. Os bochechos foram realizados a partir do primeiro atendimento clínico até o 15º dia após o início do tratamento, na frequência de duas vezes ao dia. Para avaliação da condição periodontal da amostra realizada no 1º, 7º e 15º dias foram aplicados os Índices de Sangramento Gengival (ISG) e de Placa (IP). Os pacientes foram reavaliados 7 e 15 dias após o início do uso do respectivo bochecho. Os resultados apontaram que o IP e o ISG apresentaram redução significativa nos três grupos. Quanto ao IP, o bochecho de camomila obteve a maior redução de acúmulo de placa e o bochecho de aroeira, a menor redução. Para os índices de sangramento, os resultados foram equivalentes, de forma que não foram consideradas diferenças estatisticamente significativas entre os bochechos. Foram considerados satisfatórios os bochechos a base de Camomila (Matricaria recutita L.) e Aroeira (Schinus terebinthifolius) na redução do quadro de inflamação gengival da amostra, sendo o bochecho de Camomila (Matricaria recutita L.) o que apresentou melhor desempenho na redução do índice de placa bacteriana.

This study aimed to clinically evaluate the effect of mouthwash with extracts from the medicinal plants aroeira (Schinus terebinthifolius) and chamomile (Matricaria recutita L.) on plaque control and gingivitis treatment. Thus, a randomized, double-blind interventional clinical trial was conducted, involving 59 adults treated at the Clinics of the Dentistry Program of Univ Estadual da Paraíba (UEPB). The sample consisted of patients with chronic gingivitis. This sample was randomly selected and divided into three groups: mouthwash with chlorhexidine (positive control group), mouthwash with chamomile (test group 1); mouthwash with aroeira (test group 2). During the first visit, and prior to rinses, all patients were instructed in oral hygiene and subjected to scaling and root planing procedure (SRP) of the whole mouth in one single session. Rinses occurred from the first clinical appointment to the 15th day after the beginning of treatment, twice a day. To evaluate the periodontal condition of the sample on the 1st, 7th and 15th days, Gingival Bleeding Index (GBI) and Plaque Index (PI) were used. The patients were reassessed at 7 and 15 days after the beginning of the respective rinses. Results indicated that PI and GBI significantly decreased in all three groups. As to PI, chamomile mouthwash led to the greatest reduction in plaque buildup, while aroeira mouthwash resulted in the smallest reduction. For bleeding rates, results were equivalent so that statistical differences among rinses were not considered significant. Mouthwashes with chamomile (Matricaria recutita L.) and aroeira (Schinus terebinthifolius) were considered satisfactory in reducing gingival inflammation in the sample; in addition, mouthwash with chamomile (Matricaria recutita L.) showed the best performance in reducing the plaque index.

Expansion of circulating Foxp3+)D25bright CD4+ T cells during specific venom immunotherapy.

BACKGROUND: Venom immunotherapy (VIT) induces long-lasting immune tolerance to hymenoptera venom antigens, but the underlying mechanisms are not yet clarified. Regulatory T cells are thought to play an important role in allergic diseases and tolerance induction during specific immunotherapy. AIM: Characterize longitudinally the impact of VIT on the pool of circulating regulatory T cells. METHODS: Fourteen hymenoptera venom-allergic patients with severe reactions (grades III-IV) were studied before, 6 and 12 months after starting ultra-rush VIT. Freshly isolated peripheral blood mononuclear cells were surface stained with a panel of markers of T cell differentiation and intracellularly for CTLA-4 and Foxp3 and analysed by flow cytometry. foxp3 mRNA was quantified by real-time PCR. VIT responses were assessed by measuring specific IgG4 and IgE levels. Eleven individuals with no history of insect venom allergy were studied as controls. RESULTS: VIT induces a significant progressive increase in both the proportion and the absolute numbers of regulatory T cells defined as CD25bright and/or Foxp3+ CD4+ T cells. These changes are not related to alterations in the expression of activation markers or imbalances in the naïve/memory T cell compartments. foxp3 mRNA levels also increased significantly during VIT. Of note, the increase in circulating regulatory T cell counts significantly correlates with the venom-specific IgG4/IgE ratio shift. CONCLUSION: VIT is associated with a progressive expansion of circulating regulatory T cells, supporting a role for these cells in tolerance induction.

Laparoscopic nissen fundoplication using ultrasonic cutting and coagulation.

Gastroesophageal reflux disease (GERD) is the most common foregut disorder, with 7% of Americans experiencing heartburn daily. Symptoms of GERD are many and varied, including heartburn, chest pain, regurgitation, dysphagia, nocturnal aspiration, morning hoarseness, chronic cough, and wheezing. Fifty percent of symptomatic patients develop esophagitis, while 20% of patients with esophagitis develop complications, including ulceration, stricture, Barrett's esophagus, and aspiration pneumorritis.